Intensive Nutrition Counselling in Patients With Head and Neck Cancer

Sponsor
Helsinki University Central Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02159508
Collaborator
University of Helsinki (Other), University of Eastern Finland (Other)
65
1
2
85
0.8

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the effect of a pre-planned patient-adjusted intensive nutritional counselling given by a dietitian several times during (chemo)radiotherapy vs. individualized nutritional counselling given by a dietitian once in the beginning of (chemo)radiotherapy and thereafter on-demand in patients with head and neck squamous cell cancer.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Nutritional counselling
N/A

Detailed Description

  • A sample size of 102 patients was identified to achieve 30% reduction in prevalence of malnutrition at the end of treatment (50% to 20%), with a significance value of 5% (p < 0.05), 90% power. The second calculation was for a sample size of 88 patients for 30% reduction in prevalence of malnutrition at the end of treatment (50% to 20%) with the significance value 5% (p<0.05), 85% power and effect size 70%. Based on these numbers, our aim is to recruit 100 patients, with the assumption that 12% patients would be lost to follow up.

  • Randomization will be performed by the minimization procedure with the Minim Program® (http://www-users.york.ac.uk/~mb55/guide/randsery.htm). The allocation will be done according to the following criteria: 1) Stage I-II vs. Stage III-IV; 2) age <65 vs. >=65 year; 3) Body Mass Index <20 vs. >=20 kg/m2 and 4) tumour location (oral cavity-oropharynx-tonsils vs. hypopharynx-larynx vs. nasopharynx).

  • Adverse events of chemoradiotherapy will be classified according to the National Cancer Institute Common Terminology Criteria for Adverse Events-3.0 (CTCAE v3.0)

  • Nutritional status will be assessed by patient-generated subjective global assessment, nutritional risk screening-2002, upper-arm anthropometry (MAC, triceps skinfold thickness, MAMA), Bio-impedance, hand grip strength and weight loss.

  • Survival: overall survival, disease-specific survival and disease-free survival are calculated.

Study Design

Study Type:
Interventional
Actual Enrollment :
65 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
An Intervention Study Comparing Intensive Nutrition Counselling With On-demand Counselling in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy
Study Start Date :
Nov 1, 2007
Anticipated Primary Completion Date :
Dec 1, 2014
Anticipated Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Individualised on-demand counselling

Individualized on-demand counselling group was assigned to receive baseline nutritional counselling, that consisted of one dietetic consultation before (chemo)radiotherapy. During (chemo)radiotherapy on-demand counselling group patients received further counselling only on demand.

Experimental: Intensive nutritional counselling

Intensive nutritional counselling consisted of protocolled counselling given by a dietitian once at baseline and on the 2nd and 4th week of treatment and at the end of chemoradiotherapy.

Behavioral: Nutritional counselling
In both study arms, daily estimated energy requirements were calculated from the basal energy requirements according to WHO multiplied by a 1.5 activity factor and protein requirement (g/day) was calculated multiplying ideal body weight (defined as BMI 22) by 1.2 to 1.5.

Outcome Measures

Primary Outcome Measures

  1. Nutritional status [6 months]

    Nutritional status was assessed by patient-generated subjective global assessment and anthropometry.

Secondary Outcome Measures

  1. Survival [5 year]

    Overall survival (OS) is defined as the time interval between the date of the randomization (i.e. at diagnosis) and the date of the last visit or death by any cause.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical diagnosis of primary locally advanced squamous cell carcinoma of the oral cavity, pharynx, nasopharynx or larynx
Exclusion Criteria:
  • renal function impairment

  • liver insufficiency

  • heart failure

  • pulmonal impairment

  • Chronic obstructive pulmonary disease

  • cognitive impairment

  • previous cancer in any location

  • terminal stage

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Otolaryngology - Head & Neck Surgery, Helsinki University Central Hospital and University of Helsinki Helsinki HUS Finland 00029

Sponsors and Collaborators

  • Helsinki University Central Hospital
  • University of Helsinki
  • University of Eastern Finland

Investigators

  • Study Director: Antti Mäkitie, Professor, Helsinki University Central Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Helena Orell-Kotikangas, Dietitian, Helsinki University Central Hospital
ClinicalTrials.gov Identifier:
NCT02159508
Other Study ID Numbers:
  • 322-E9-05
First Posted:
Jun 10, 2014
Last Update Posted:
Jun 10, 2014
Last Verified:
May 1, 2014
Keywords provided by Helena Orell-Kotikangas, Dietitian, Helsinki University Central Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 10, 2014